@MartinVuilleme@socialwork I think travelling in a car (and possibly walking together) reduces the focus on the interaction itself and sometimes leads to more flowing conversations.
I didn't realize this was going to become a series... (Part of the
GHOSTS IN THE MACHINE Series Apparently)
So I watched a "theoretical" YouTube video yesterday in which they
report from multiple sources on a story linking TikTok influencer Hailey
Lujan to possibly being a government Psyop. At the very least, she says
lots of pro-Army things and gets to play with $100,000s of dollars in
cool hardware that civilians just don't normally get access to.
Apparently the Army is targeting the first-person shooter gamer
community (there is some evidence they may be better at piloting drones
than pilots) -- quoted to be about 93-96% male, young, and many of them
lonely. The term "parasocial" is getting thrown around here -- which is
a one-sided relationship, sometimes quite intense, usually referring to
relationships between celebrities and their audience. The video quotes
some research that the subset of these young men who are almost always
online "are almost never interacting with young women -- instead there
is a trend of parasocial relationships forming...".
The joke I now have with my wife is that YouTube's algorithm will start
flooding our joint account with "E-Girls" dressed in camouflage.
[And, well ick -- this strange story is now starting to intersect with
my other essay series about "Sigma Males" and that bogus personality
type being associated with very similar lonely young men. See: https://mastodon.clinicians-exchange.org/@admin/109705551829241507 ]
Given the number of articles online about Army recruiting on TikTok, and
that Hailey Lujan reportedly has a LinkedIn profile as being in the army
with Psyops ( https://www.linkedin.com/in/hailey-lujan-a2707819a ), I'm
not sure how "theoretical" it really is.
I'm not 100% sure I'm against this sort of influence campaign but I need
to know more. We do need recruits in the USA Armed Forces and they are
missing their recruiting targets a lot recently.
First Sent: 6/5/23
TITLE: GHOSTS IN THE MACHINE
<https://m.youtube.com/watch?v=VA4e0NqyYMw>
This has been out for a year, but I had not seen it.
This is supposedly put out by the the US Army's PSYOPS (Psychological
Operations) unit out of Fort Bragg.
**The video is intended as a recruiting tool.**
Well -- it's creepy -- I'll give them that.
I suppose if we want recruits angry and ready to do anything to
manipulate the world -- it is successful.
And I find myself both getting angry towards the end, AND trying to
catch what subliminal messaging they are inserting.
What do you think about this kind of recruiting, assuming that is what
it is?
Fair warning -- It is disturbing, threatening, and creepy.
<https://m.youtube.com/watch?v=VA4e0NqyYMw>
Michael Reeder LCPC
Baltimore, MD
#psychology #neurology #socialwork #psychiatry @[email protected]
@[email protected] @[email protected] #mentalhealth
#psychotherapists @[email protected] #PSYOPS #goarmy
#manipulation #army #armyrecruiting #recruiting #creepy #war #weapons
#USA #cyberwar #lonely
#healthcare <<https://mastodon.clinicians-exchange.org/tags/healthcare>>
#depression <<https://mastodon.clinicians-exchange.org/tags/depression>>
#psychotherapist
<<https://mastodon.clinicians-exchange.org/tags/psychotherapist>>
#military <<https://mastodon.clinicians-exchange.org/tags/military>>
#militarypsych
<<https://mastodon.clinicians-exchange.org/tags/militarypsych>>
#militarypsychology
<<https://mastodon.clinicians-exchange.org/tags/militarypsychology>>
#militarycounseling
<<https://mastodon.clinicians-exchange.org/tags/militarycounseling>> #APA
<<https://mastodon.clinicians-exchange.org/tags/APA>> #Division19
<<https://mastodon.clinicians-exchange.org/tags/Division19>>
#militaryhealth
<<https://mastodon.clinicians-exchange.org/tags/militaryhealth>>
#DeploymentPsychology
<<https://mastodon.clinicians-exchange.org/tags/DeploymentPsychology>>
#UniformServicesUniversity
<<https://mastodon.clinicians-exchange.org/tags/UniformServicesUniversity>>
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @[email protected]
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <https://www.nationalpsychologist.com>
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
<http://subscribe-article-digests.clinicians-exchange.org>
.
READ ONLINE: <http://read-the-rss-mega-archive.clinicians-exchange.org>
It's primitive... but it works... mostly...
This instance proved uniquely unpopular despite lots of marketing. I'll get around to removing the links to it in bot posts and emails and Mastodon graphics eventually.
It might have made sense to keep it open if Lemmy was going to offer private forums for vetted members anytime in the near future (therapists like privacy in discussions) but this objective is barely on the developer's radars.
I am definitely keeping https://mastodon.clinicians-exchange.org open and would encourage you to join that site if you are in need of a Mastodon instance and work at all broadly speaking in the field of mental health.
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: A new study finds SARS-CoV-2 directly infects the coronary
vasculature and causes plaque inflammation, which could help explain
why people with COVID-19 have an increased risk for ischemic
cardiovascular complications up to 1 year after infection (see
"COVID-19 Virus Infects Coronary Vasculature" under COVID
Complications).
People with rheumatic disease and a history of a specific type of cold
virus infection called OC43 are at elevated risk for developing long
COVID (see "A Common Cold Might Set Some Up for Long COVID" under
Virology & Epidemiology).
Two scientists who pioneered an underlying technology to harness
fragile genetic material in a way that ultimately resulted in the mRNA
vaccines used to combat the COVID-19 pandemic were named winners of
the Nobel Prize in medicine (see "Pair of Trailblazers of mRNA Vaccine
Science Win Nobel Prize" under Media News).
When used against current strains of COVID-19, Pfizer's antiviral
Paxlovid is less effective at preventing hospitalization or death in
high-risk patients. But when looking at death alone, the antiviral is
still highly effective (see "Paxlovid Weaker Against Current COVID-19
Variants" under Vaccinations, Treatment & Testing).
Average levels of SARS-CoV-2, the virus that causes COVID, being found
in wastewater are down about 5%, compared to last week (see
"Wastewater Data Hint at Possible COVID Decline in Some Areas" under
Virology & Epidemiology).
A panel of independent advisers to the Centers for Disease Control and
Prevention (CDC) will meet next month to make recommendations on
updated COVID-19 vaccines ahead of the fall season (see "CDC Advisers
Set to Vote on Updated COVID Vaccines Next Month" under Policy).
A long-term study indicates a correlation between COVID-19 and lasting
cardiovascular impairment (see "Cardiovascular Assessment up to One
Year After COVID-19 Vaccine–Associated Myocarditis" under COVID
Complications).
Mean weekly cannabis-involved ED visits among all young persons were
higher during the COVID-19 pandemic in 2020, 2021, and 2022 (see
"Cannabis-Involved Emergency Department Visits Among Persons Aged <25
Years Before and During the COVID-19 Pandemic" under COVID
Complications).
As the rollout of the newly formulated COVID-19 booster shot begins in
earnest, many Americans are finding roadblocks (see "Shortages, Cost,
and Frustration: Quest for the New COVID Shot" under Policy).
Relatives of COVID ICU patients demonstrate a range of coping styles
and impact on quality of life (see "Quality of Life and Coping With
Stress in Relatives of Patients in Intensive Care Units During
COVID-19" under COVID Complications).
The biotech Moderna said Wednesday that its first combination vaccine,
which protects against influenza and Covid-19, had succeeded in an
early-stage trial and could be ready to launch as soon as 2025 (see
"Moderna’s Combo Vaccine Moves Towards Late-Stage Trial" under
Vaccines, Treatment & Testing).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @PsychResearchBot
This AI will follow along and take the session notes for the doctor by
listening to the office visit. It will also bring up charts and records
through voice command and prompt the doctor to do routine things during
the office visit. It's due out early next year.
This could be very helpful.
However I can imagine a few kinks in the office visit process initially:
Patient: "Doctor, my knee hurts"
AI: "REMEMBER TO MAKE A FOLLOW-UP APPOINTMENT"
Patient: "What was that?!"
Doctor: "Oh pay no attention -- that is just the new AI system everyone
has to consent to for treatment. It will help us during the session."
AI: "HAVE YOU EXAMINED THE KNEE X-RAY YET?"
Doctor: "AI, pull up the knee x-ray"
Patient: "This is my first visit, there is no knee x-ray yet."
AI: "REMEMBER TO SCHEDULE A KNEE X-RAY"
Doctor & Patient Together: "We don't know if we need a knee x-ray yet!"
Patient: "It started hurting yesterday"
Doctor: "Jump up on the table and I'll take a look at it"
AI: "SHALL I SUMMON A NURSE TO WATCH TO GUARD AGAINST ALLEGATIONS OF
IMPROPRIETY?"
Doctor: "NO!"
Doctor: "It does look a bit red. Does this hurt?"
Patient: "A bit when you touch there and I bend it."
AI: "SHALL I SCHEDULE THE KNEE X-RAY NOW?"
Doctor: "SHUT UP! AI -- Silent mode now!"
Office visits are going to be fun the next few years while this gets sorted.
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @PsychResearchBot
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Open LEMMY instance for all mental health workers: https://lem.clinicians-exchange.org
.
If you ever wonder why psychotherapists sometimes stop taking insurance
in the United States, there are lots of reasons. Low pay is the typical
one.
Hassle is another.
I'm trying to catch-up on billing this fine Sunday afternoon. The last
thing I need is a billing rabbit hole to get stuck in...
Today's rabbit hole -- trying to figure out why once of my insurance
panels keeps paying significantly different rates on the same CPT 90837
billing code (the code for a roughly one hour session). A LARGE
difference in fact.
Took a long time... drum roll...
I'm paid LESS for POS 02 (place of service telehealth AWAY from home)
versus POS 10 (place of service telehealth AT home).
Cause, yeah -- that makes sense.
So, yes, I'm required to code whether or not a client is at home for
telehealth. Why? No idea. (I suppose I do need to know the address
in case I need to send an ambulance or something.)
This all was made especially fun by:
a) The insurance company does not publish a rate schedule. No way to
know if I'd get a check or a claw-back if I inquire about the discrepancy.
b) The client has co-insurance. So the co-insurance rate varies by
place of service (POS) too. Client pays a percentage (%) of the total
amount I'm due.
It's crazy-making. And "crazy" is a term I usually avoid. Except when
discussion the American health system.
TITLE: Psilocybin‐assisted psychotherapy for treatment‐resistant
depression: Which psychotherapy?
From the abstract, looks like interpersonal psychotherapy and intensive
short-term dynamic psychotherapy are the most promising candidates.
I'll have to give this a full read later.
This might be of special interest to psychotherapists in and around
Washington, DC which has legalized psilocybin. Of course, it being
available recreationally is not the same as a therapeutic regime -- but
therapeutic clinics are emerging rapidly in the area.
TITLE: Good Therapy Credit Card Info and Security / 3rd Party Tracking
Yes, I actually do ask myself why I bother anymore, in case you are
wondering.
This stuff is so ubiquitous now as to be all but unavoidable.
That said, perhaps multiple letters from their customers (such as the
one below) might sway thinking?
www.goodtherapy.org
Dear Good Therapy Support:
[email protected]
I just updated my payment information with a new credit card.
In order to do this, I had to turn off "Brave Shields" -- basically a
web browser feature that blocks 3rd party tracking (cookies, web
beacons, sending data out to outside URLs). The web page would not
display with shields up.
*In payment transactions on multiple other websites I have NEVER had to
turn off my 3rd party tracking blockers.**
*
This is disconcerting -- makes me wonder how secure your website is.
Please consider changing this.
Also -- although I will never use your Good Therapy Verified Seal widget
-- its abilities to collect data for tracking, analysis, and advertising
from mental health websites is in very poor judgement. This stops only
just slightly short of a HIPAA violation as anyone looking at a
therapist's website is certainly considering mental health help. Data
from multiple such widgets and trackers across websites is used all the
time by 3rd party aggregators to discover the full name and identity of
visitors.
This is disappointing behavior that has lowered my trust in your
organization.
Thanks,
Michael Reeder
#psychology #counseling #socialwork #psychotherapy #legal
@[email protected] @[email protected]
@[email protected] @[email protected] @[email protected]
@[email protected] #mentalhealth #technology #psychiatry #healthcare
#HIPAA #dataprotection #infosec @[email protected] #doctors #hospitals
#BAA #businessassociateagreement #patientprivacy #goodtherapy
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: Hospitalizations from COVID-19 rose for an eighth straight
week to 18,871 people/week see "COVID Hospitalizations Rise for Eighth
Week in a Row" under Virology & Epidemiology).
Moderna says its upcoming COVID-19 vaccine should work against the
BA.2.86 variant that has caused worry about a possible surge in cases
(see "New Moderna Vaccine to Work Against Recent COVID Variant" under
Vaccomes, Treatment & Testing).
COVID vaccines will have a new formulation this year, according to a
decision announced today by the US Food and Drug Administration that
will focus efforts on circulating variants. The move pushes last
year's bivalent vaccines out of circulation because they will no
longer be authorized for use in the United States (see "New COVID
Vaccines Force Bivalents Out" under Policy).
The CDC is not specifically saying whether long COVID patients should
get the new COVID boosters, flu shots, or RSV vaccines, and the Food
and Drug Administration (FDA) referred similar questions to the CDC
(see "Should Long COVID Patients Get the Flu, RSV, and New Booster
Shots?" under Policy).
Research continues to show that early intervention with antibiotics
reduces the risk of fatality from COID-19 (see "Early Empiric
Antibiotic Use in Patients Hospitalized With COVID-19" under Vaccines,
Treatment & Testing).
In ICU-patients ≥70 years old, COVID-19 is associated with greater
mortality rates than bacterial or viral pneumonia (see "Increased
Mortality in ICU Patients ≥70 Years Old With COVID-19 Compared to
Patients With Other Pneumonias" under COVID Complications).
After the US Food and Drug Administration authorized new monovalent
COVID vaccines, the CDC recommended the new booster vaccinations for
everyone (see "Universal Monovalent COVID Vaccines Backed by CDC"
under Policy).
About 103 million Americans had COVID-19, and about a third of those
led to long COVID. New data indicate that some cases of long COVID-19
might be going unidentified because the patient's initial infection
wasn't detected (see "Some People With Long COVID Tested Negative for
COVID-19" under COVID Complications).
Although SARS-CoV-2 infection among young children typically results
in mild infection, it can result in serious illness, including
multisystem inflammatory syndrome in children, long-term sequalae, and
death. mRNA COVID-19 vaccination provides protection against
symptomatic SARS-CoV-2 infection for at least 4 months after
vaccination among children aged 3–5 years (see "Safety Monitoring of
mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5
Years" under Vaccines, Treatment & Testing).
A new meta-analysis has shown that SGLT2 inhibitors do not lead to
lower 28-day all-cause mortality compared with usual care or placebo
in patients hospitalized with COVID-19 (see "SGLT2-inhibitors: No
Benefit in Hospitalized COVID-19" under Vaccines, Treatment &
Testing).
The COVID-19 booster vaccine typically causes transient, clinically
insignificant elevations in glucose levels in people with type 1
diabetes (see "COVID Booster May Transiently Raise Glucose Levels in
T1D" under Vaccines, Treatment & Testing).
"Cost May Lead Many to Skip COVID Testing: Why That's a Problem" (see
under Media News).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog #stillnotover
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: The updated vaccine that better protects against currently
circulating strains of the virus that causes COVID-19 may be available
as soon as next week (see "New COVID Shots Could Be Available Next
Week" under Vaccines, Treatment & Testing).
The increase in cases of COVID-19 in the northern hemisphere is
worrying healthcare authorities around the world, who are aware that
these countries usually experience a peak in respiratory infections
during the winter months (see "WHO 'Concerned' About COVID Increase in
Northern Hemisphere" under Virology & Epidemiology).
COVID-19 hospitalizations have been on the rise for weeks as summer
nears its end. COVID-19 hospitalizations rose by 19% last week and
COVID deaths by 21%, according to figures from the CDC. More than half
the states, 26, had a "substantial increase" in hospital admissions
(see "COVID-19 Hospitalizations and Deaths on the Rise" and "5
Questions for COVID Experts: How Concerned Should We Be?" under
Virology & Epidemiology).
COVID metrics have risen steadily since June after reaching the lowest
point since the pandemic started. However, just 7% of U.S. adults are
"very worried" about getting COVID-19 (see "COVID Metrics Tick Up, but
Americans Aren't Worried: Poll" under Media News).
The CDC and the World Health Organization have dubbed the BA 2.86
variant of COVID-19 as a variant to watch (see "Q&A: What to Know
About the New BA 2.86 COVID Variant" under Virology & Epidemiology).
However, BA.2.86 does not have a heightened ability to evade the
protection of COVID vaccines or immunity from prior infection (see
"Highly Mutated COVID Strain Can't Evade Immunity as Feared" under
Virology & Epidemiology).
Close and prolonged contact with someone with COVID-19 can more than
quadruple the risk of getting the virus (see "This Is When You're Most
at Risk for 'Leaky' COVID Immunity" under Virology & Epidemiology).
It's estimated that 1 out of 8 people with COVID develop long COVID.
Of those persons, 44% also experience headaches. Research has found
that many of those headaches are migraines — and many patients who are
afflicted say they had never had a migraine before (see "Long COVID
and New Migraines: What's the Link?" under COVID Complications).
Severe COVID infections may lead to lasting damage to the immune
system (see "Severe COVID May Cause Long-Term Cellular Changes: Study"
under COVID Complications).
COVID-19 may negatively affect the wound healing process while
increasing the mortality rate amongst patients with multiple or severe
comorbidities undergoing limb salvage procedure (see "Retrospective
Review of Complications and Outcomes in COVID-19–Positive Patients
With Comorbidities Undergoing Limb Salvage Procedures in a Tertiary
Care Wound Center" under COVID Complications).
Among patients with ARF due to COVID-19 pneumonia who fail HFNC, delay
of intubation beyond 24 h is associated with increased mortality (see
"Delayed Intubation Associated With In-hospital Mortality in Patients
With COVID-19" under Vaccines, treatment & Testing).
Crippling symptoms, lost careers, and eroded incomes: This is the
harsh reality for doctors suffering with long COVID, according to the
first major survey of physicians with the condition (see "One in Five
Doctors With Long COVID Can No Longer Work: Survey" under COVID
Complications).
EU regulators have recommended authorizing an updated COVID-19 vaccine
from Pfizer and its German partner BioNTech which targets the dominant
XBB.1.5 variant of Omicron, putting it on track to become the third
adapted shot by the two companies to be approved in the bloc (see "EU
Regulators Back Pfizer's Updated Vaccine for Dominant Omicron
Subvariant" under Policy).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
Charles M. Lepkowsky, Ph.D.
Solvang, CA
clepkowsky(at)gmail.com
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
Okay all -- It's early days for figuring out how to help people with
Long COVID.
That said, a bit of promising research is starting to surface.
I'm taking the unusual step of emailing EVERYONE because at this point
many of you with anxiety and depression symptoms may have some Long
COVID (brain fog, sleep issues, the depression or anxiety itself!).
A good write-up about what Long COVID is can be found here. Yes, you
can had a trivial case of COVID-19 and still get Long COVID symptoms for
days, weeks, months, or years. Some cases of it are somewhat "mild": https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
*The bottom-line of the video is right at the end. For long COVID:
-- Get outside one hour per day.
-- May cover up if sensitive to sun (near UV rays will get through
clothing anyway)
-- Best if in nature (surrounded by green)
-- Do not look directly at sun (duh)
-- May wear a hat (near UV rays will get through clothing anyway)
-- Sitting in a sunny window no longer good enough (most glass now has
to be certified to block the rays we want)
He also promises to talk about how intermittent fasting may help in a
future video.
*
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical
Care, and Sleep Medicine and an Associate Professor at the University of
California, Riverside School of Medicine. He is also an ER doctor.
Before the pandemic, MedCram mainly seemed to be training for doctors to
pass exams. Since the start of COVID, Dr. Seheult has done occasional
more accessible videos for the general public on COVID-related topics.
To actually understand why something this simple may help -- and listen
to some research, please watch:
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]